Kevin Scranton

Kevin Scranton has a diverse work experience in various industries. Kevin started their career as a Clinical Intern at the CATCH the Virus Research Study in September 2017. During their time there, they collected and analyzed human biological samples and entered participant data into study databases.

In November 2017, Kevin joined the Alpha Tau Omega Fraternity as a Philanthropy Chair, where they likely managed philanthropic and fundraising activities.

Then, they worked at GreenSmith PR as a Client Specialist in July 2018. Their responsibilities included analyzing legislation to secure funding for bio-tech and pharmaceutical start-ups and collaborating with congressmen and legislative staff to request funds for SBIR grants.

In January 2020, Kevin became a Healthcare Client Specialist at Venn Strategies, a role they held until April 2020. Details about their responsibilities for this position are not provided.

Kevin's next role was at Lyndra Therapeutics, starting in September 2020. Kevin served as a Senior Manufacturing Technician, specializing in laser welding and following cGMP standards to produce a novel drug delivery system aimed at improving medication adherence.

In November 2021, Kevin transitioned to the role of Associate Clinical Data Scientist at Lyndra Therapeutics. Further details about this role are not provided.

Prior to their professional career, Kevin was a student at the University of Maryland from August 2016 to September 2020.

Kevin Scranton attended the University of Maryland from 2016 to 2020, where they pursued a Bachelor's degree in Public Health.